• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Journal Scan: Xylitol ingestion in dogsa retrospective evaluation of the consequences

February 1, 2016
Jennifer L. Garcia, DVM, DACVIM

Hospitalization and continued monitoring are recommended, even if a patient presents as euglycemic after ingestion.

Why they did it

As the popularity of xylitol as a sugar substitute increases, so does the risk of accidental ingestion by dogs. The authors of this retrospective evaluation sought to determine the prevalence, clinical signs, selected serum chemistry profile values, treatment and outcome of dogs known or suspected to have ingested xylitol.

What they did

As part of a retrospective evaluation, the researchers evaluated data from 192 dogs presented to three university teaching hospitals for known or suspected xylitol ingestion between December 2007 and February 2012. When the quantity of xylitol ingested was unknown, the maximum possible quantity was recorded.

What they found

Xylitol-containing gum was the product ingested in 96% of the cases. Each piece of gum was assumed to contain 0.3 grams of xylitol if xylitol was not listed as the first sugar alcohol and 1 gram if it was listed as the first sugar alcohol. The study authors found that 20% (n = 39) of dogs had clinical signs at the time of presentation; vomiting was most common (n = 25). The median estimated ingested dose of xylitol was 0.32 g/kg, and the amount of xylitol ingested appeared to correlate to severity of clinical signs but was not necessarily associated with the degree of hypoglycemia.

Advertisement

Overall, 15.6% (n = 30) dogs became hypoglycemic at some point during their hospitalization (glucose ≤ 60 mg/dl [3.3 mmol/L]). In 11 of 139 dogs, the blood glucose concentration nadir was not reached until ≥ 12 hours after admission. One dog continued to have seizure activity even after correction of hypoglycemia and required anticonvulsant therapy; the dog was successfully weaned off the anticonvulsant one week after discharge from the hospital. The authors also noted that there was no difference between dogs that were symptomatic or asymptomatic with respect to blood glucose concentration at presentation, lowest blood glucose concentration during hospitalization, body weight or age. There was no significant difference between the amount of xylitol ingested between dogs that developed hypoglycemia (0.23 g/kg) and those that remained euglycemic (0.35 g/kg, P = 0.25).

A serum chemistry profile was performed in 71.3% (n = 137) of the dogs, and 21.9% (n= 30) of these dogs experienced an elevation in the alanine aminotransferase (ALT) activity or serum total bilirubin concentration during hospitalization. Four of these dogs had an ALT activity > 800 U/L. None of these four dogs were hypoglycemic on presentation. There was no significant difference between the amount of xylitol ingested between dogs that developed elevations in ALT activity and/or total bilirubin concentration (0.42 g/kg; range 0.04 to 2.86 g/kg) and those with ALT activities and total bilirubin concentrations within the reference range (P = 0.07). The authors found, however, that dogs with elevated ALT activity and/or serum total bilirubin concentration experienced a significantly more profound hypoglycemic nadir. There was no difference among dogs with increased versus normal liver values with respect to age, body weight or initial blood glucose concentration.

The median duration of hospitalization was 18 hours (n = 122; range 1 to 70 hours), and all of the dogs were discharged from the hospital. At 28 days, 158 of the dogs were known to be alive, and the rest were lost to follow-up. Among the 60 dogs with recheck data, dogs with elevated liver values at the time of dismissal were clinically normal and had values that had decreased by the time of the recheck.

Take-home message

All dogs that ingest xylitol should be hospitalized for serial monitoring of blood glucose concentrations as this can decrease even in dogs that are euglycemic at the time of presentation. Dogs that do not develop evidence of liver failure after xylitol ingestion have an excellent prognosis.  

DuHadway MR, Sharp CR, Meyers KE, et al. Retrospective evaluation of xylitol ingestion in dogs: 192 cases (2007-2012). J Vet Emerg Crit Care 2015;25(5):649-654.

Link to article: http://onlinelibrary.wiley.com/doi/10.1111/vec.12350/abstract

Related Content:

Clinical
3 categories of inappetence in dogs
3 categories of inappetence in dogs
UC Davis oral surgeons repair kitten’s severe cleft palate
UC Davis oral surgeons repair kitten’s severe cleft palate
Dermatology expert explains the PSPP system when dealing with ear disease
Dermatology expert explains the PSPP system when dealing with ear disease

Advertisement

Latest News

Maryland Zoo giraffe Willow dies suddenly

3 Must-sees from the Fetch Charlotte conference

Morris Animal Foundation appoints new chief program officer

CDC issues warning over cat-transmitted sporotrichosis

View More Latest News
Advertisement